July 30, 2015
When the World Health Organization released an announcement in Vancouver this month that its updated and highly anticipated HIV treatment guidelines were "moving towards" advising treatment for all people living with HIV, the international agency noted that the recommendations follow scientific evidence from three major clinical research trials showing that immediate access to antiretroviral treatment protects health and prevents HIV transmission. It also noted challenges, that, all the same, may slow worldwide embrace of those recommendations.
Those included barriers still standing between marginalized and criminalized populations and access to HIV treatment under current guidelines, current unmet needs and gaps in delivery of services, and continuing lags in addressing HIV coinfections of tuberculosis and hepatitis.
Now a web portal from the International Association of Providers of AIDS Care provides a picture of how the world has responded so far to existing guidelines, which include treatment access for children, pregnant women, people coinfected with tuberculosis, and for infected individuals whose immune cell -- or CD4 -- count has dropped to 500 or less per cubic millimeter of blood (more or less a drop of blood). The site, HivPolicyWatch.org, which currently incorporates the policies of 149 countries on an interactive map, shows widening inequities, leadership, examples of what countries with a wide range of resources consider possible and necessary, and offers a chance to follow and compare country policies in real time as they continue to evolve.
This excerpt was cross-posted with the permission of Science Speaks. Read the full article.
|More on HIV Treatment in the Developing World|
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.